
Dr Jose Pablo Leone on where extrapolating female breast cancer data to men holds up and where it falls short, from endocrine therapy to PARP inhibitors.

Jose Pablo Leone, MD, is a medical oncologist and clinical investigator in the Breast Oncology Center at Dana-Farber Cancer Institute and an associate professor of medicine at Harvard Medical School in Boston, Massachusetts. He also serves as Director of the Program for Breast Cancer in Men.